Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

enVVeno Medical (NVNO) Change in Accured Expenses (2017 - 2020)

enVVeno Medical has reported Change in Accured Expenses over the past 4 years, most recently at $660194.0 for Q4 2020.

  • Quarterly results put Change in Accured Expenses at $660194.0 for Q4 2020, up 495.97% from a year ago — trailing twelve months through Dec 2020 was $614428.0 (up 1178.7% YoY), and the annual figure for FY2025 was $1000.0, down 99.86%.
  • Change in Accured Expenses for Q4 2020 was $660194.0 at enVVeno Medical, up from -$169737.0 in the prior quarter.
  • Over the last five years, Change in Accured Expenses for NVNO hit a ceiling of $670878.0 in Q2 2018 and a floor of -$524672.0 in Q3 2018.
  • Median Change in Accured Expenses over the past 4 years was $29374.0 (2019), compared with a mean of $47140.6.
  • Biggest five-year swings in Change in Accured Expenses: tumbled 356.58% in 2018 and later surged 495.97% in 2020.
  • enVVeno Medical's Change in Accured Expenses stood at $86701.0 in 2017, then tumbled by 356.58% to -$222460.0 in 2018, then rose by 25.05% to -$166728.0 in 2019, then surged by 495.97% to $660194.0 in 2020.
  • The last three reported values for Change in Accured Expenses were $660194.0 (Q4 2020), -$169737.0 (Q3 2020), and $94105.0 (Q2 2020) per Business Quant data.